12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga · 4d ago
Gainers
- Cognition Therapeutics (NASDAQ:CGTX) shares rose 22.9% to $0.44 during Thursday's pre-market session. The market value of their outstanding shares is at $27.0 million. As per the press release, Q1 earnings came out yesterday.
- Emergent BioSolutions (NYSE:EBS) shares moved upwards by 18.55% to $5.62. The market value of their outstanding shares is at $305.3 million. The company's, Q1 earnings came out yesterday.
- Mira Pharmaceuticals (NASDAQ:MIRA) stock rose 16.37% to $1.35. The market value of their outstanding shares is at $22.3 million.
- Aveanna Healthcare Hldgs (NASDAQ:AVAH) shares moved upwards by 16.18% to $5.6. The market value of their outstanding shares is at $1.0 billion. As per the press release, Q1 earnings came out today.
- Novavax (NASDAQ:NVAX) stock moved upwards by 12.94% to $6.72. The company's market cap stands at $1.0 billion. As per the news, the Q1 earnings report came out today.
- Akebia Therapeutics (NASDAQ:AKBA) shares increased by 12.6% to $2.77. The company's market cap stands at $723.6 million. As per the press release, Q1 earnings came out today.
Losers
- NuCana (NASDAQ:NCNA) stock declined by 63.4% to $0.11 during Thursday's pre-market session.
- Accelerate Diagnostics (NASDAQ:AXDX) stock fell 29.2% to $0.33. The company's market cap stands at $8.2 million.
- electroCore (NASDAQ:ECOR) shares fell 14.69% to $5.81. The market value of their outstanding shares is at $41.7 million. As per the press release, Q1 earnings came out yesterday.
- Exagen (NASDAQ:XGN) shares decreased by 13.47% to $5.91. The market value of their outstanding shares is at $106.3 million. The company's, Q1 earnings came out 3 days ago.
- ZyVersa Therapeutics (NASDAQ:ZVSA) shares declined by 13.32% to $0.59. The market value of their outstanding shares is at $2.1 million.
- LogicMark (NASDAQ:LGMK) stock decreased by 12.5% to $0.01. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.